Thursday, June 25, 2015

FDA slaps U.S. drugmaker over drug testing issues - FiercePharma Manufacturing

Read the full article: FDA slaps U.S. drugmaker over drug testing issues - FiercePharma Manufacturing:

"Inspectors were particularly troubled with batch testing after inspectors found "multiple incidents of inaccurate batch production records containing erroneous statements, including results that were not derived from analytical testing" or from certificates of analysis (CoAs) of its suppliers."

'via Blog this'

You might also be interested in the following GMP training course:

Return to SkillsPlus International Info Blog - Home

SkillsPlus Intl Inc. - The Best GMP & QSR Compliance Training Around

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.